hispidulin and Pneumonia--Staphylococcal

hispidulin has been researched along with Pneumonia--Staphylococcal* in 1 studies

Other Studies

1 other study(ies) available for hispidulin and Pneumonia--Staphylococcal

ArticleYear
Natural flavone hispidulin protects mice from Staphylococcus aureus pneumonia by inhibition of α-hemolysin production via targeting AgrA
    Microbiological research, 2022, Volume: 261

    The emergence of drug-resistant Staphylococcus aureus (S. aureus) has limited drug options for the clinical treatment of S. aureus infections. Considering recent reports, therapeutic strategies targeting bacterial virulence hold great promise, and alpha-hemolysin (encoded by hla), a critical virulence factor of S. aureus, plays a vital role during bacterial infection. Herein, we demonstrated that hispidulin effectively inhibited the hemolytic activity of S. aureus USA300 without suppressing bacterial growth, along with inhibiting hla transcription and expression in a dose-dependent manner. As heptamer formation is essential for hla-mediated invasion of cells, nevertheless, hispidulin did not affect the deoxycholate-induced oligomerization of hla, suggesting that hispidulin did not affect the protein activity of hla. In vitro assays illustrated that hispidulin bound to agrA

    Topics: Animals; Bacterial Proteins; Bacterial Toxins; Flavones; Hemolysin Proteins; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus

2022